New research from the University of Virginia School of Medicine has shed light on how chronic stress and obesity may contribute to type 2 diabetes. The findings point the finger at an unexpected biological perpetrator – the breakdown of fat.

University of Virginia psychology professor examines the taste system.

When it comes to the future of medicine, small is indeed beautiful. Working at the nanoscale, tens of thousands of researchers are in a race to develop tiny nanoparticles, nanodevices and nanopatterned surfaces for medical applications. Their goals are both comprehensive and ambitious. They are hoping to create drugs that stop disease processes at the molecular level where they start, engineer drug delivery systems that are small enough to reach deep within the body and build scaffolding and textured surfaces that the body can use to regenerate lost or damaged tissue.

Graduate students might seem to live in some sort of parallel existence, immersed in esoteric research that the person on the street can’t understand.

Its name is Rivanna, and it’s the University of Virginia’s new $2.4 million Cray computing cluster, a high-performance machine – really a combination of linked high-power computers (hence, “cluster”) – designed to greatly enhance and establish computationally intensive and data-intensive research at the University.

The number of women being trained to enter engineering, science and social science academic careers is not the cause of female underrepresentation in those fields, attendees at a University of Virginia seminar on faculty hiring learned last week.

The University of Virginia recently announced (Jan. 30) the commitment of a $10 million gift that establishes an endowment to support its new Data Science Institute.